Innovation Origins
•Science
Science
86% Informative
Researchers the University of Manchester ester have found ab first l behaviour in monocytes.
This could be used as drug targets for treating long-COVID symptoms.
Lo COVID VID can lead to debilitating symptoms such as extreme fatigue The University of Manchester si Manchester University NHS Foundation Trust sc MFT r d Northern Care Alliance Foundation Trust r NCA n year the National Institute for Health and Care Research hL NIHR Text__NxlGi">first Conclusion S1 first yFeed_high Elizabeth Mann Gi University of Manchester class="summaryFeed_highLightText__NxlGi">mono monocyte an> COVID-19 ghtText__NxlGi">COVID-19 first lass="summaryFeed_highLightText__NxlGi">COVID-19 the European Respiratory Journal xlGi">first 71 span> COVID-19 ext__ 142 Gi">years months t__NxlGi">months COVID-19 ummaryFeed_highLightText__NxlGi">myalgia< monocyte Dr Mann up to nine months
VR Score
86
Informative language
88
Neutral language
29
Article tone
formal
Language
English
Language complexity
69
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
5
Source diversity
5
Affiliate links
no affiliate links